These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2696574)

  • 1. Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells?
    Hertz L
    Brain Res Brain Res Rev; 1989; 14(4):335-53. PubMed ID: 2696574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal and glial calcium signaling in Alzheimer's disease.
    Mattson MP; Chan SL
    Cell Calcium; 2003; 34(4-5):385-97. PubMed ID: 12909083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
    Hertz L; Chen Y; Waagepetersen HS
    J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Flux Balance Analysis Predicts that Stimulation of Energy Metabolism in Astrocytes and their Metabolic Interactions with Neurons Depend on Uptake of K
    DiNuzzo M; Giove F; Maraviglia B; Mangia S
    Neurochem Res; 2017 Jan; 42(1):202-216. PubMed ID: 27628293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.
    Allaman I; Gavillet M; Bélanger M; Laroche T; Viertl D; Lashuel HA; Magistretti PJ
    J Neurosci; 2010 Mar; 30(9):3326-38. PubMed ID: 20203192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glia interactions as therapeutic targets in neurodegeneration.
    Salmina AB
    J Alzheimers Dis; 2009; 16(3):485-502. PubMed ID: 19276541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.
    Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations.
    Mann DM
    Mech Ageing Dev; 1985 Sep; 31(3):213-55. PubMed ID: 3906293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited.
    Marczynski TJ
    Brain Res Bull; 1998; 45(4):341-79. PubMed ID: 9527011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of glial metabolism studied by 13C-NMR.
    Zwingmann C; Leibfritz D
    NMR Biomed; 2003; 16(6-7):370-99. PubMed ID: 14679501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.
    Robinson SR
    Neurochem Int; 2000 Apr; 36(4-5):471-82. PubMed ID: 10733015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications.
    Arranz AM; De Strooper B
    Lancet Neurol; 2019 Apr; 18(4):406-414. PubMed ID: 30795987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.
    Bondareff W; Mountjoy CQ; Roth M; Hauser DL
    Neurobiol Aging; 1989; 10(6):709-15. PubMed ID: 2628782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and metabolism-related Ca2+ and mitochondrial dynamics in co-cultured human fetal cortical neurons and astrocytes.
    Fu W; Ruangkittisakul A; MacTavish D; Baker GB; Ballanyi K; Jhamandas JH
    Neuroscience; 2013 Oct; 250():520-35. PubMed ID: 23876319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM; Gershon S
    FASEB J; 1990 Jul; 4(10):2745-52. PubMed ID: 2165009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced neuronal activity and reactivation in Alzheimer's disease.
    Swaab DF; Lucassen PJ; Salehi A; Scherder EJ; van Someren EJ; Verwer RW
    Prog Brain Res; 1998; 117():343-77. PubMed ID: 9932420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration.
    Vardjan N; Verkhratsky A; Zorec R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal-glial interactions and behaviour.
    Laming PR; Kimelberg H; Robinson S; Salm A; Hawrylak N; Müller C; Roots B; Ng K
    Neurosci Biobehav Rev; 2000 May; 24(3):295-340. PubMed ID: 10781693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.